DTaP5-IPV-Hib-HepB, a hexavalent vaccine for infants and toddlers
Introduction: Combination vaccines reduce the 'shot burden' and simplify the childhood immunization schedule. Only 5-valent DTaP-based vaccines are licensed in the U.S. Areas covered: A new combination vaccine - DTaP5-IPV-Hib-HepB - is described, which induces antibody responses in infants...
Saved in:
Main Authors: | Andrew W. Lee (Author), Emilia Jordanov (Author), Florence Boisnard (Author), Gary S. Marshall (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and immunogenicity of a fully-liquid DTaP-IPV-Hib-HepB vaccine (Vaxelis™) in premature infants
by: Marissa B. Wilck, et al.
Published: (2021) -
DTaP-IPV-HB-Hib vaccine (Hexaxim): an update 10 years after first licensure
by: Florence Boisnard, et al.
Published: (2023) -
Demonstration of durable hepatitis B immune memory in children vaccinated with a DTaP5-IPV-HepB-Hib infant-toddler series 7 to 8 years previously
by: Anitta Ahonen, et al.
Published: (2022) -
A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016)
by: Andrea Guerra, et al.
Published: (2024) -
A review of the DTaP-IPV-HB-PRP-T Hexavalent vaccine in pediatric patients
by: Andrew Dakin, et al.
Published: (2023)